Marker at the estrogen receptor gene for determination of osteoporosis predisposition
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 10, 1998
Issued Date -
N/A
app pub date -
Jul 14, 1997
filing date -
Jan 25, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a method of determining predisposition to low or high bone mineral density and to development of osteoporosis of a patient, which comprises determining estrogen receptor polymorphism in linkage disequilibrium in a biological sample of said patient, wherein heterozygosity is associated with high bone density and homozygosity is associated with low bone density.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully